Young L - Search Results

1

Raised plasma endostatin levels correlate inversely with breast cancer angiogenesis.

Teh SH, Hill AD, Lee AW, Foley D, Kennedy S, Young L, McDermott E, O'Higgins N. Teh SH, et al. Among authors: young l. J Surg Res. 2004 Jan;116(1):165-71. doi: 10.1016/s0022-4804(03)00282-8. J Surg Res. 2004. PMID: 14732364

2

Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.

Fleming FJ, Hill AD, McDermott EW, O'Higgins NJ, Young LS. Fleming FJ, et al. J Clin Endocrinol Metab. 2004 Jan;89(1):375-83. doi: 10.1210/jc.2003-031048. J Clin Endocrinol Metab. 2004. PMID: 14715875

3

COX inhibitors modulate bFGF-induced cell survival in MCF-7 breast cancer cells.

Teh SH, Hill AK, Foley DA, McDermott EW, O'Higgins NJ, Young LS. Teh SH, et al. J Cell Biochem. 2004 Mar 1;91(4):796-807. doi: 10.1002/jcb.10767. J Cell Biochem. 2004. PMID: 14991771

4

Expression of SRC-1, AIB1, and PEA3 in HER2 mediated endocrine resistant breast cancer; a predictive role for SRC-1.

Fleming FJ, Myers E, Kelly G, Crotty TB, McDermott EW, O'Higgins NJ, Hill AD, Young LS. Fleming FJ, et al. Among authors: young ls. J Clin Pathol. 2004 Oct;57(10):1069-74. doi: 10.1136/jcp.2004.016733. J Clin Pathol. 2004. PMID: 15452162 Free PMC article.

5

Inverse relationship between ER-beta and SRC-1 predicts outcome in endocrine-resistant breast cancer.

Myers E, Fleming FJ, Crotty TB, Kelly G, McDermott EW, O'higgins NJ, Hill AD, Young LS. Myers E, et al. Among authors: young ls. Br J Cancer. 2004 Nov 1;91(9):1687-93. doi: 10.1038/sj.bjc.6602156. Br J Cancer. 2004. PMID: 15477868 Free PMC article.

6

Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer.

Myers E, Hill AD, Kelly G, McDermott EW, O'Higgins NJ, Buggy Y, Young LS. Myers E, et al. Clin Cancer Res. 2005 Mar 15;11(6):2111-22. doi: 10.1158/1078-0432.CCR-04-1192. Clin Cancer Res. 2005. PMID: 15788656

7

Expression of the breast cancer metastasis suppressor gene, BRMS1, in human breast carcinoma: lack of correlation with metastasis to axillary lymph nodes.

Kelly LM, Buggy Y, Hill A, O'Donovan N, Duggan C, McDermott EW, O'Higgins NJ, Young L, Duffy MJ. Kelly LM, et al. Among authors: young l. Tumour Biol. 2005 Jul-Aug;26(4):213-6. doi: 10.1159/000086955. Epub 2005 Jul 6. Tumour Biol. 2005. PMID: 16006775

8

A positive role for PEA3 in HER2-mediated breast tumour progression.

Myers E, Hill AD, Kelly G, McDermott EW, O'Higgins NJ, Young LS. Myers E, et al. Among authors: young ls. Br J Cancer. 2006 Nov 20;95(10):1404-9. doi: 10.1038/sj.bjc.6603427. Epub 2006 Oct 24. Br J Cancer. 2006. PMID: 17060941 Free PMC article.

9

Tamoxifen-induced ER-alpha-SRC-3 interaction in HER2 positive human breast cancer; a possible mechanism for ER isoform specific recurrence.

Mc Ilroy M, Fleming FJ, Buggy Y, Hill AD, Young LS. Mc Ilroy M, et al. Endocr Relat Cancer. 2006 Dec;13(4):1135-45. doi: 10.1677/erc.1.01222. Endocr Relat Cancer. 2006. PMID: 17158759

10

Growth factor-dependent regulation of survivin by c-myc in human breast cancer.

Cosgrave N, Hill AD, Young LS. Cosgrave N, et al. J Mol Endocrinol. 2006 Dec;37(3):377-90. doi: 10.1677/jme.1.02118. J Mol Endocrinol. 2006. PMID: 17170079

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,156 results

Search Page

Filters